Release Date: 15/02/23 08:01 Summary: Change in substantial holding from MIN Price Sensitive: No Download Document 397.31KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%